Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals

Keyphrases

• Allopurinol 33%
• Amphotericin B 33%
• Animal Hosts 33%
• Antileishmanial Activity 33%
• Antileishmanial Compounds 33%
• Balb C Mice 33%
• Benzethonium Chloride 33%
• Cetalkonium Chloride 33%
• Chloride 33%
• Cotrimoxazole 33%
• Cutaneous Leishmaniasis 100%
• Dimethyl Sulfoxide 33%
• Emetine 33%
• Experimental Animals 100%
• Healing 33%
• Hydrochloride 33%
• Leishmania Major 100%
• Metronidazole 33%
• Ointment 66%
• Paraffin 33%
• Paromomycin 33%
• Patent Application 33%
• Pentamidine 33%
• Rifampin 33%
• Sodium Stibogluconate 33%
• Topical Treatment 100%
• Twice Daily 33%
• United Kingdom 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Allopurinol 50%
• Amphotericin B 50%
• Bagg Albino Mouse 50%
• Benzethonium Chloride 50%
• Cetalkonium Chloride 50%
• Cotrimoxazole 50%
• Dimethyl Sulfoxide 50%
• Elimination 50%
• Emetine 50%
• Experimental Animal 100%
• Leishmania Major 100%
• Liquid Paraffin 50%
• Methylbenzethonium Chloride 50%
• Metronidazole 50%
• Mouse 50%
• Paromomycin 50%
• Pentamidine 50%
• Rifampicin 50%
• Skin Leishmaniasis 100%
• Sodium Stibogluconate 50%